nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Estropipate—osteoporosis	0.0933	0.181	CbGbCtD
Budesonide—CYP3A4—Calcitriol—osteoporosis	0.0933	0.181	CbGbCtD
Budesonide—CYP3A4—Ergocalciferol—osteoporosis	0.0746	0.145	CbGbCtD
Budesonide—CYP3A4—Raloxifene—osteoporosis	0.0623	0.121	CbGbCtD
Budesonide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0601	0.117	CbGbCtD
Budesonide—CYP3A4—Cholecalciferol—osteoporosis	0.0481	0.0934	CbGbCtD
Budesonide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0441	0.0858	CbGbCtD
Budesonide—CYP3A4—Estradiol—osteoporosis	0.0388	0.0753	CbGbCtD
Budesonide—Testolactone—CYP19A1—osteoporosis	0.00156	0.491	CrCbGaD
Budesonide—Hydrocortisone—SHBG—osteoporosis	0.00065	0.205	CrCbGaD
Budesonide—Betamethasone—CYP19A1—osteoporosis	0.000611	0.193	CrCbGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00039	0.0931	CbGpPWpGaD
Budesonide—Dexamethasone—CYP19A1—osteoporosis	0.000356	0.112	CrCbGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.000305	0.0728	CbGpPWpGaD
Budesonide—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000303	0.0722	CbGpPWpGaD
Budesonide—Pruritus—Estropipate—osteoporosis	0.000274	0.000574	CcSEcCtD
Budesonide—Discomfort—Zoledronate—osteoporosis	0.000274	0.000573	CcSEcCtD
Budesonide—Asthenia—Alendronate—osteoporosis	0.000274	0.000573	CcSEcCtD
Budesonide—Hypersensitivity—Ibandronate—osteoporosis	0.000274	0.000573	CcSEcCtD
Budesonide—Cough—Conjugated Estrogens—osteoporosis	0.000274	0.000573	CcSEcCtD
Budesonide—Dyspnoea—Risedronate—osteoporosis	0.000273	0.000571	CcSEcCtD
Budesonide—Dry mouth—Zoledronate—osteoporosis	0.000271	0.000568	CcSEcCtD
Budesonide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000271	0.000567	CcSEcCtD
Budesonide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000271	0.000567	CcSEcCtD
Budesonide—Pruritus—Alendronate—osteoporosis	0.00027	0.000565	CcSEcCtD
Budesonide—Dyspepsia—Risedronate—osteoporosis	0.00027	0.000564	CcSEcCtD
Budesonide—Eye disorder—Estradiol—osteoporosis	0.00027	0.000564	CcSEcCtD
Budesonide—Constipation—Ethinyl Estradiol—osteoporosis	0.000269	0.000562	CcSEcCtD
Budesonide—Confusional state—Zoledronate—osteoporosis	0.000268	0.000561	CcSEcCtD
Budesonide—Hypersensitivity—Calcitriol—osteoporosis	0.000268	0.000561	CcSEcCtD
Budesonide—Flushing—Estradiol—osteoporosis	0.000268	0.00056	CcSEcCtD
Budesonide—Cardiac disorder—Estradiol—osteoporosis	0.000268	0.00056	CcSEcCtD
Budesonide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000267	0.000559	CcSEcCtD
Budesonide—Myalgia—Conjugated Estrogens—osteoporosis	0.000267	0.000559	CcSEcCtD
Budesonide—Chest pain—Conjugated Estrogens—osteoporosis	0.000267	0.000559	CcSEcCtD
Budesonide—Asthenia—Ibandronate—osteoporosis	0.000267	0.000558	CcSEcCtD
Budesonide—Anxiety—Conjugated Estrogens—osteoporosis	0.000266	0.000557	CcSEcCtD
Budesonide—Nausea—Etidronic acid—osteoporosis	0.000266	0.000557	CcSEcCtD
Budesonide—Anaphylactic shock—Zoledronate—osteoporosis	0.000266	0.000556	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000265	0.000555	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000265	0.000555	CcSEcCtD
Budesonide—Diarrhoea—Estropipate—osteoporosis	0.000265	0.000555	CcSEcCtD
Budesonide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000264	0.000553	CcSEcCtD
Budesonide—Infection—Zoledronate—osteoporosis	0.000264	0.000553	CcSEcCtD
Budesonide—Fatigue—Risedronate—osteoporosis	0.000264	0.000552	CcSEcCtD
Budesonide—Insomnia—Pamidronate—osteoporosis	0.000263	0.000551	CcSEcCtD
Budesonide—Pruritus—Ibandronate—osteoporosis	0.000263	0.00055	CcSEcCtD
Budesonide—Pain—Risedronate—osteoporosis	0.000262	0.000548	CcSEcCtD
Budesonide—Constipation—Risedronate—osteoporosis	0.000262	0.000548	CcSEcCtD
Budesonide—Angiopathy—Estradiol—osteoporosis	0.000262	0.000548	CcSEcCtD
Budesonide—Shock—Zoledronate—osteoporosis	0.000262	0.000547	CcSEcCtD
Budesonide—Paraesthesia—Pamidronate—osteoporosis	0.000261	0.000547	CcSEcCtD
Budesonide—Diarrhoea—Alendronate—osteoporosis	0.000261	0.000546	CcSEcCtD
Budesonide—Asthenia—Calcitriol—osteoporosis	0.000261	0.000546	CcSEcCtD
Budesonide—Nervous system disorder—Zoledronate—osteoporosis	0.000261	0.000546	CcSEcCtD
Budesonide—Immune system disorder—Estradiol—osteoporosis	0.000261	0.000545	CcSEcCtD
Budesonide—Mediastinal disorder—Estradiol—osteoporosis	0.00026	0.000544	CcSEcCtD
Budesonide—Dyspnoea—Pamidronate—osteoporosis	0.00026	0.000543	CcSEcCtD
Budesonide—Tachycardia—Zoledronate—osteoporosis	0.00026	0.000543	CcSEcCtD
Budesonide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000259	0.000542	CcSEcCtD
Budesonide—Somnolence—Pamidronate—osteoporosis	0.000259	0.000542	CcSEcCtD
Budesonide—Skin disorder—Zoledronate—osteoporosis	0.000258	0.00054	CcSEcCtD
Budesonide—Pruritus—Calcitriol—osteoporosis	0.000257	0.000539	CcSEcCtD
Budesonide—Hyperhidrosis—Zoledronate—osteoporosis	0.000257	0.000538	CcSEcCtD
Budesonide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000257	0.000537	CcSEcCtD
Budesonide—Diarrhoea—Raloxifene—osteoporosis	0.000257	0.000537	CcSEcCtD
Budesonide—Dyspepsia—Pamidronate—osteoporosis	0.000256	0.000536	CcSEcCtD
Budesonide—Dizziness—Estropipate—osteoporosis	0.000256	0.000536	CcSEcCtD
Budesonide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000256	0.000536	CcSEcCtD
Budesonide—Alopecia—Estradiol—osteoporosis	0.000255	0.000533	CcSEcCtD
Budesonide—Infection—Conjugated Estrogens—osteoporosis	0.000254	0.000532	CcSEcCtD
Budesonide—Diarrhoea—Ibandronate—osteoporosis	0.000254	0.000532	CcSEcCtD
Budesonide—Anorexia—Zoledronate—osteoporosis	0.000254	0.00053	CcSEcCtD
Budesonide—Decreased appetite—Pamidronate—osteoporosis	0.000253	0.00053	CcSEcCtD
Budesonide—Mental disorder—Estradiol—osteoporosis	0.000253	0.000529	CcSEcCtD
Budesonide—Dizziness—Alendronate—osteoporosis	0.000252	0.000528	CcSEcCtD
Budesonide—Shock—Conjugated Estrogens—osteoporosis	0.000252	0.000527	CcSEcCtD
Budesonide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000251	0.000526	CcSEcCtD
Budesonide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000251	0.000525	CcSEcCtD
Budesonide—Malnutrition—Estradiol—osteoporosis	0.000251	0.000525	CcSEcCtD
Budesonide—Fatigue—Pamidronate—osteoporosis	0.000251	0.000525	CcSEcCtD
Budesonide—Gastrointestinal pain—Risedronate—osteoporosis	0.00025	0.000524	CcSEcCtD
Budesonide—Tachycardia—Conjugated Estrogens—osteoporosis	0.00025	0.000523	CcSEcCtD
Budesonide—Urticaria—Ethinyl Estradiol—osteoporosis	0.00025	0.000522	CcSEcCtD
Budesonide—Pain—Pamidronate—osteoporosis	0.000249	0.000521	CcSEcCtD
Budesonide—Constipation—Pamidronate—osteoporosis	0.000249	0.000521	CcSEcCtD
Budesonide—Diarrhoea—Calcitriol—osteoporosis	0.000249	0.000521	CcSEcCtD
Budesonide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000249	0.00052	CcSEcCtD
Budesonide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000248	0.00052	CcSEcCtD
Budesonide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000248	0.00052	CcSEcCtD
Budesonide—Dizziness—Raloxifene—osteoporosis	0.000248	0.000519	CcSEcCtD
Budesonide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000248	0.000518	CcSEcCtD
Budesonide—Flatulence—Estradiol—osteoporosis	0.000247	0.000518	CcSEcCtD
Budesonide—Tension—Estradiol—osteoporosis	0.000246	0.000516	CcSEcCtD
Budesonide—Vomiting—Estropipate—osteoporosis	0.000246	0.000516	CcSEcCtD
Budesonide—Dysgeusia—Estradiol—osteoporosis	0.000246	0.000515	CcSEcCtD
Budesonide—Dizziness—Ibandronate—osteoporosis	0.000246	0.000514	CcSEcCtD
Budesonide—Rash—Estropipate—osteoporosis	0.000244	0.000511	CcSEcCtD
Budesonide—Dermatitis—Estropipate—osteoporosis	0.000244	0.000511	CcSEcCtD
Budesonide—Anorexia—Conjugated Estrogens—osteoporosis	0.000244	0.000511	CcSEcCtD
Budesonide—Nervousness—Estradiol—osteoporosis	0.000244	0.00051	CcSEcCtD
Budesonide—Urticaria—Risedronate—osteoporosis	0.000243	0.000509	CcSEcCtD
Budesonide—Back pain—Estradiol—osteoporosis	0.000243	0.000508	CcSEcCtD
Budesonide—Headache—Estropipate—osteoporosis	0.000243	0.000508	CcSEcCtD
Budesonide—Vomiting—Alendronate—osteoporosis	0.000243	0.000508	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000242	0.000507	CcSEcCtD
Budesonide—Body temperature increased—Risedronate—osteoporosis	0.000242	0.000507	CcSEcCtD
Budesonide—Abdominal pain—Risedronate—osteoporosis	0.000242	0.000507	CcSEcCtD
Budesonide—Muscle spasms—Estradiol—osteoporosis	0.000241	0.000505	CcSEcCtD
Budesonide—Rash—Alendronate—osteoporosis	0.000241	0.000504	CcSEcCtD
Budesonide—Insomnia—Zoledronate—osteoporosis	0.000241	0.000503	CcSEcCtD
Budesonide—Dermatitis—Alendronate—osteoporosis	0.00024	0.000503	CcSEcCtD
Budesonide—Feeling abnormal—Pamidronate—osteoporosis	0.00024	0.000502	CcSEcCtD
Budesonide—Headache—Alendronate—osteoporosis	0.000239	0.0005	CcSEcCtD
Budesonide—Paraesthesia—Zoledronate—osteoporosis	0.000239	0.0005	CcSEcCtD
Budesonide—Vomiting—Raloxifene—osteoporosis	0.000239	0.000499	CcSEcCtD
Budesonide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000238	0.000498	CcSEcCtD
Budesonide—Dyspnoea—Zoledronate—osteoporosis	0.000237	0.000496	CcSEcCtD
Budesonide—Rash—Raloxifene—osteoporosis	0.000237	0.000495	CcSEcCtD
Budesonide—Dermatitis—Raloxifene—osteoporosis	0.000236	0.000495	CcSEcCtD
Budesonide—Somnolence—Zoledronate—osteoporosis	0.000236	0.000495	CcSEcCtD
Budesonide—Vomiting—Ibandronate—osteoporosis	0.000236	0.000494	CcSEcCtD
Budesonide—Tremor—Estradiol—osteoporosis	0.000235	0.000492	CcSEcCtD
Budesonide—Headache—Raloxifene—osteoporosis	0.000235	0.000492	CcSEcCtD
Budesonide—Rash—Ibandronate—osteoporosis	0.000234	0.00049	CcSEcCtD
Budesonide—Dermatitis—Ibandronate—osteoporosis	0.000234	0.00049	CcSEcCtD
Budesonide—Dyspepsia—Zoledronate—osteoporosis	0.000234	0.00049	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000233	0.000488	CcSEcCtD
Budesonide—Ill-defined disorder—Estradiol—osteoporosis	0.000233	0.000487	CcSEcCtD
Budesonide—Headache—Ibandronate—osteoporosis	0.000233	0.000487	CcSEcCtD
Budesonide—Insomnia—Conjugated Estrogens—osteoporosis	0.000232	0.000485	CcSEcCtD
Budesonide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000231	0.000484	CcSEcCtD
Budesonide—Vomiting—Calcitriol—osteoporosis	0.000231	0.000484	CcSEcCtD
Budesonide—Decreased appetite—Zoledronate—osteoporosis	0.000231	0.000484	CcSEcCtD
Budesonide—Agitation—Estradiol—osteoporosis	0.000231	0.000483	CcSEcCtD
Budesonide—Nausea—Estropipate—osteoporosis	0.00023	0.000482	CcSEcCtD
Budesonide—Abdominal pain—Pamidronate—osteoporosis	0.00023	0.000482	CcSEcCtD
Budesonide—Body temperature increased—Pamidronate—osteoporosis	0.00023	0.000482	CcSEcCtD
Budesonide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00023	0.000481	CcSEcCtD
Budesonide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00023	0.00048	CcSEcCtD
Budesonide—Angioedema—Estradiol—osteoporosis	0.000229	0.00048	CcSEcCtD
Budesonide—Rash—Calcitriol—osteoporosis	0.000229	0.00048	CcSEcCtD
Budesonide—Fatigue—Zoledronate—osteoporosis	0.000229	0.00048	CcSEcCtD
Budesonide—Dermatitis—Calcitriol—osteoporosis	0.000229	0.000479	CcSEcCtD
Budesonide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000228	0.000478	CcSEcCtD
Budesonide—Headache—Calcitriol—osteoporosis	0.000228	0.000477	CcSEcCtD
Budesonide—Somnolence—Conjugated Estrogens—osteoporosis	0.000228	0.000476	CcSEcCtD
Budesonide—Pain—Zoledronate—osteoporosis	0.000227	0.000476	CcSEcCtD
Budesonide—Constipation—Zoledronate—osteoporosis	0.000227	0.000476	CcSEcCtD
Budesonide—Nausea—Alendronate—osteoporosis	0.000227	0.000474	CcSEcCtD
Budesonide—Malaise—Estradiol—osteoporosis	0.000226	0.000474	CcSEcCtD
Budesonide—Hypersensitivity—Risedronate—osteoporosis	0.000226	0.000472	CcSEcCtD
Budesonide—Vertigo—Estradiol—osteoporosis	0.000226	0.000472	CcSEcCtD
Budesonide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000225	0.000472	CcSEcCtD
Budesonide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000225	0.000472	CcSEcCtD
Budesonide—Syncope—Estradiol—osteoporosis	0.000225	0.000471	CcSEcCtD
Budesonide—Nausea—Raloxifene—osteoporosis	0.000223	0.000467	CcSEcCtD
Budesonide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000223	0.000466	CcSEcCtD
Budesonide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000222	0.000465	CcSEcCtD
Budesonide—Palpitations—Estradiol—osteoporosis	0.000222	0.000464	CcSEcCtD
Budesonide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000221	0.000463	CcSEcCtD
Budesonide—Fatigue—Conjugated Estrogens—osteoporosis	0.000221	0.000462	CcSEcCtD
Budesonide—Nausea—Ibandronate—osteoporosis	0.000221	0.000462	CcSEcCtD
Budesonide—Loss of consciousness—Estradiol—osteoporosis	0.000221	0.000462	CcSEcCtD
Budesonide—Asthenia—Risedronate—osteoporosis	0.00022	0.00046	CcSEcCtD
Budesonide—Feeling abnormal—Zoledronate—osteoporosis	0.000219	0.000459	CcSEcCtD
Budesonide—Cough—Estradiol—osteoporosis	0.000219	0.000458	CcSEcCtD
Budesonide—Constipation—Conjugated Estrogens—osteoporosis	0.000219	0.000458	CcSEcCtD
Budesonide—Pain—Conjugated Estrogens—osteoporosis	0.000219	0.000458	CcSEcCtD
Budesonide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000217	0.000455	CcSEcCtD
Budesonide—Hypertension—Estradiol—osteoporosis	0.000217	0.000454	CcSEcCtD
Budesonide—Pruritus—Risedronate—osteoporosis	0.000217	0.000453	CcSEcCtD
Budesonide—Nausea—Calcitriol—osteoporosis	0.000216	0.000452	CcSEcCtD
Budesonide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000215	0.00045	CcSEcCtD
Budesonide—Hypersensitivity—Pamidronate—osteoporosis	0.000215	0.000449	CcSEcCtD
Budesonide—Chest pain—Estradiol—osteoporosis	0.000214	0.000447	CcSEcCtD
Budesonide—Myalgia—Estradiol—osteoporosis	0.000214	0.000447	CcSEcCtD
Budesonide—Arthralgia—Estradiol—osteoporosis	0.000214	0.000447	CcSEcCtD
Budesonide—Anxiety—Estradiol—osteoporosis	0.000213	0.000446	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000212	0.000444	CcSEcCtD
Budesonide—Urticaria—Zoledronate—osteoporosis	0.000211	0.000442	CcSEcCtD
Budesonide—Discomfort—Estradiol—osteoporosis	0.000211	0.000442	CcSEcCtD
Budesonide—Abdominal pain—Zoledronate—osteoporosis	0.00021	0.00044	CcSEcCtD
Budesonide—Body temperature increased—Zoledronate—osteoporosis	0.00021	0.00044	CcSEcCtD
Budesonide—Diarrhoea—Risedronate—osteoporosis	0.00021	0.000438	CcSEcCtD
Budesonide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000209	0.000438	CcSEcCtD
Budesonide—Dry mouth—Estradiol—osteoporosis	0.000209	0.000437	CcSEcCtD
Budesonide—Asthenia—Pamidronate—osteoporosis	0.000209	0.000437	CcSEcCtD
Budesonide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000208	0.000435	CcSEcCtD
Budesonide—Confusional state—Estradiol—osteoporosis	0.000207	0.000432	CcSEcCtD
Budesonide—Pruritus—Pamidronate—osteoporosis	0.000206	0.000431	CcSEcCtD
Budesonide—Anaphylactic shock—Estradiol—osteoporosis	0.000205	0.000429	CcSEcCtD
Budesonide—Infection—Estradiol—osteoporosis	0.000204	0.000426	CcSEcCtD
Budesonide—Urticaria—Conjugated Estrogens—osteoporosis	0.000203	0.000426	CcSEcCtD
Budesonide—Dizziness—Risedronate—osteoporosis	0.000203	0.000424	CcSEcCtD
Budesonide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000202	0.000424	CcSEcCtD
Budesonide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000202	0.000424	CcSEcCtD
Budesonide—Shock—Estradiol—osteoporosis	0.000202	0.000422	CcSEcCtD
Budesonide—Nervous system disorder—Estradiol—osteoporosis	0.000201	0.000421	CcSEcCtD
Budesonide—Tachycardia—Estradiol—osteoporosis	0.0002	0.000418	CcSEcCtD
Budesonide—Vomiting—Ethinyl Estradiol—osteoporosis	0.0002	0.000418	CcSEcCtD
Budesonide—Diarrhoea—Pamidronate—osteoporosis	0.000199	0.000417	CcSEcCtD
Budesonide—Skin disorder—Estradiol—osteoporosis	0.000199	0.000416	CcSEcCtD
Budesonide—Hyperhidrosis—Estradiol—osteoporosis	0.000198	0.000415	CcSEcCtD
Budesonide—Rash—Ethinyl Estradiol—osteoporosis	0.000198	0.000414	CcSEcCtD
Budesonide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000198	0.000414	CcSEcCtD
Budesonide—Headache—Ethinyl Estradiol—osteoporosis	0.000197	0.000412	CcSEcCtD
Budesonide—Hypersensitivity—Zoledronate—osteoporosis	0.000196	0.00041	CcSEcCtD
Budesonide—Vomiting—Risedronate—osteoporosis	0.000195	0.000407	CcSEcCtD
Budesonide—Rash—Risedronate—osteoporosis	0.000193	0.000404	CcSEcCtD
Budesonide—Dermatitis—Risedronate—osteoporosis	0.000193	0.000404	CcSEcCtD
Budesonide—Dizziness—Pamidronate—osteoporosis	0.000193	0.000403	CcSEcCtD
Budesonide—Headache—Risedronate—osteoporosis	0.000192	0.000401	CcSEcCtD
Budesonide—Asthenia—Zoledronate—osteoporosis	0.000191	0.000399	CcSEcCtD
Budesonide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000189	0.000395	CcSEcCtD
Budesonide—Pruritus—Zoledronate—osteoporosis	0.000188	0.000394	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000187	0.000391	CcSEcCtD
Budesonide—Nausea—Ethinyl Estradiol—osteoporosis	0.000187	0.00039	CcSEcCtD
Budesonide—Insomnia—Estradiol—osteoporosis	0.000185	0.000388	CcSEcCtD
Budesonide—Vomiting—Pamidronate—osteoporosis	0.000185	0.000387	CcSEcCtD
Budesonide—Paraesthesia—Estradiol—osteoporosis	0.000184	0.000385	CcSEcCtD
Budesonide—Asthenia—Conjugated Estrogens—osteoporosis	0.000184	0.000384	CcSEcCtD
Budesonide—Rash—Pamidronate—osteoporosis	0.000184	0.000384	CcSEcCtD
Budesonide—Dermatitis—Pamidronate—osteoporosis	0.000183	0.000384	CcSEcCtD
Budesonide—Dyspnoea—Estradiol—osteoporosis	0.000183	0.000382	CcSEcCtD
Budesonide—Headache—Pamidronate—osteoporosis	0.000182	0.000382	CcSEcCtD
Budesonide—Somnolence—Estradiol—osteoporosis	0.000182	0.000381	CcSEcCtD
Budesonide—Diarrhoea—Zoledronate—osteoporosis	0.000182	0.000381	CcSEcCtD
Budesonide—Nausea—Risedronate—osteoporosis	0.000182	0.000381	CcSEcCtD
Budesonide—Pruritus—Conjugated Estrogens—osteoporosis	0.000181	0.000379	CcSEcCtD
Budesonide—Dyspepsia—Estradiol—osteoporosis	0.00018	0.000377	CcSEcCtD
Budesonide—Decreased appetite—Estradiol—osteoporosis	0.000178	0.000373	CcSEcCtD
Budesonide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000177	0.00037	CcSEcCtD
Budesonide—Fatigue—Estradiol—osteoporosis	0.000177	0.00037	CcSEcCtD
Budesonide—Dizziness—Zoledronate—osteoporosis	0.000176	0.000368	CcSEcCtD
Budesonide—Pain—Estradiol—osteoporosis	0.000175	0.000367	CcSEcCtD
Budesonide—Constipation—Estradiol—osteoporosis	0.000175	0.000367	CcSEcCtD
Budesonide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000175	0.000367	CcSEcCtD
Budesonide—Nausea—Pamidronate—osteoporosis	0.000173	0.000362	CcSEcCtD
Budesonide—Dizziness—Conjugated Estrogens—osteoporosis	0.000169	0.000354	CcSEcCtD
Budesonide—Vomiting—Zoledronate—osteoporosis	0.000169	0.000354	CcSEcCtD
Budesonide—Feeling abnormal—Estradiol—osteoporosis	0.000169	0.000353	CcSEcCtD
Budesonide—Rash—Zoledronate—osteoporosis	0.000168	0.000351	CcSEcCtD
Budesonide—Gastrointestinal pain—Estradiol—osteoporosis	0.000168	0.000351	CcSEcCtD
Budesonide—Dermatitis—Zoledronate—osteoporosis	0.000168	0.000351	CcSEcCtD
Budesonide—Headache—Zoledronate—osteoporosis	0.000167	0.000349	CcSEcCtD
Budesonide—Vomiting—Conjugated Estrogens—osteoporosis	0.000163	0.000341	CcSEcCtD
Budesonide—Urticaria—Estradiol—osteoporosis	0.000163	0.000341	CcSEcCtD
Budesonide—Abdominal pain—Estradiol—osteoporosis	0.000162	0.000339	CcSEcCtD
Budesonide—Body temperature increased—Estradiol—osteoporosis	0.000162	0.000339	CcSEcCtD
Budesonide—Rash—Conjugated Estrogens—osteoporosis	0.000161	0.000338	CcSEcCtD
Budesonide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000161	0.000337	CcSEcCtD
Budesonide—Headache—Conjugated Estrogens—osteoporosis	0.00016	0.000336	CcSEcCtD
Budesonide—Nausea—Zoledronate—osteoporosis	0.000158	0.000331	CcSEcCtD
Budesonide—Nausea—Conjugated Estrogens—osteoporosis	0.000152	0.000318	CcSEcCtD
Budesonide—Hypersensitivity—Estradiol—osteoporosis	0.000151	0.000316	CcSEcCtD
Budesonide—Asthenia—Estradiol—osteoporosis	0.000147	0.000308	CcSEcCtD
Budesonide—Pruritus—Estradiol—osteoporosis	0.000145	0.000303	CcSEcCtD
Budesonide—Diarrhoea—Estradiol—osteoporosis	0.00014	0.000293	CcSEcCtD
Budesonide—Dizziness—Estradiol—osteoporosis	0.000136	0.000284	CcSEcCtD
Budesonide—Vomiting—Estradiol—osteoporosis	0.00013	0.000273	CcSEcCtD
Budesonide—Rash—Estradiol—osteoporosis	0.000129	0.00027	CcSEcCtD
Budesonide—Dermatitis—Estradiol—osteoporosis	0.000129	0.00027	CcSEcCtD
Budesonide—Headache—Estradiol—osteoporosis	0.000128	0.000269	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000125	0.0299	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000125	0.0298	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000123	0.0293	CbGpPWpGaD
Budesonide—Nausea—Estradiol—osteoporosis	0.000122	0.000255	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.00011	0.0263	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000109	0.0261	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000107	0.0254	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000105	0.025	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—VDR—osteoporosis	9.9e-05	0.0236	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	9.86e-05	0.0235	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	9.83e-05	0.0234	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	9.28e-05	0.0221	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	9.24e-05	0.0221	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	8.43e-05	0.0201	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	7.83e-05	0.0187	CbGpPWpGaD
Budesonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	7.57e-05	0.0181	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—ESR1—osteoporosis	7.57e-05	0.0181	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	6.24e-05	0.0149	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—WNT1—osteoporosis	6.11e-05	0.0146	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	5.98e-05	0.0143	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	5.82e-05	0.0139	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	5.68e-05	0.0135	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—BMP2—osteoporosis	5.53e-05	0.0132	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	5.41e-05	0.0129	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	4.95e-05	0.0118	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	4.89e-05	0.0117	CbGpPWpGaD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	4.67e-05	0.0111	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	4.64e-05	0.0111	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	4.58e-05	0.0109	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	4.13e-05	0.00985	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	4.03e-05	0.00962	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.02e-05	0.00958	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	3.68e-05	0.00878	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.58e-05	0.00855	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	3.22e-05	0.00768	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IRS2—osteoporosis	3.03e-05	0.00722	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LEP—osteoporosis	2.96e-05	0.00707	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IRS1—osteoporosis	2.64e-05	0.00631	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.6e-05	0.00621	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.57e-05	0.00613	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	2.47e-05	0.00588	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IGF1—osteoporosis	2.45e-05	0.00584	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	2.41e-05	0.00576	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	2.41e-05	0.00575	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	2.15e-05	0.00512	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	2.15e-05	0.00512	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—U2AF1—osteoporosis	2.14e-05	0.0051	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	2.13e-05	0.00509	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.11e-05	0.00503	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	2.1e-05	0.00502	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	1.82e-05	0.00433	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	1.7e-05	0.00406	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.63e-05	0.00389	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	1.6e-05	0.00381	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPL24—osteoporosis	1.59e-05	0.00379	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.56e-05	0.00373	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TGFB1—osteoporosis	1.47e-05	0.0035	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—osteoporosis	1.37e-05	0.00327	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	1.35e-05	0.00322	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.27e-05	0.00302	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.18e-05	0.00283	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.12e-05	0.00267	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—osteoporosis	1.11e-05	0.00264	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.11e-05	0.00264	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	1.03e-05	0.00246	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	9.56e-06	0.00228	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PSMA2—osteoporosis	9.18e-06	0.00219	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PSMA5—osteoporosis	9.18e-06	0.00219	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR2—osteoporosis	8.2e-06	0.00196	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—POMC—osteoporosis	6.74e-06	0.00161	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—VDR—osteoporosis	6.51e-06	0.00155	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FDPS—osteoporosis	6.35e-06	0.00152	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PKM—osteoporosis	6.35e-06	0.00152	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PGLS—osteoporosis	6.02e-06	0.00144	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPD2—osteoporosis	6.02e-06	0.00144	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ATIC—osteoporosis	5.51e-06	0.00131	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PNP—osteoporosis	5.51e-06	0.00131	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	5.37e-06	0.00128	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR1—osteoporosis	4.97e-06	0.00119	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—OXCT1—osteoporosis	4.68e-06	0.00112	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA2—osteoporosis	4.68e-06	0.00112	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MGLL—osteoporosis	4.56e-06	0.00109	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—IDH2—osteoporosis	3.88e-06	0.000926	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.65e-06	0.00087	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACP5—osteoporosis	3.55e-06	0.000846	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TPI1—osteoporosis	3.3e-06	0.000787	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—P4HB—osteoporosis	3.1e-06	0.00074	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GAPDH—osteoporosis	3.04e-06	0.000726	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—RAP1A—osteoporosis	2.97e-06	0.000707	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—osteoporosis	2.59e-06	0.000617	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENO1—osteoporosis	2.4e-06	0.000572	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PSMA2—osteoporosis	2.36e-06	0.000563	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PSMA5—osteoporosis	2.36e-06	0.000563	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.92e-06	0.000457	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADCY5—osteoporosis	1.57e-06	0.000373	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX1—osteoporosis	1.56e-06	0.000372	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—osteoporosis	1.44e-06	0.000343	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—POMC—osteoporosis	1.15e-06	0.000275	CbGpPWpGaD
